Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2023	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.72	0.06	0.34	5.33	0.34
Cash & Short-Term Investments	0.72	0.06	0.34	5.33	0.34
Cash Growth	-86.40%	-83.25%	-93.69%	1484.83%	-
Other Receivables	-	3.67	0.06	0.1	0.06
Total Trade Receivables	-	3.67	0.06	0.1	0.06
Other Current Assets	0.48	1.56	2.72	1.77	2.72
Total Current Assets	1.2	5.28	3.11	7.2	3.11
Net Property, Plant & Equipment	0.01	0	0	0	0
Long-Term Investments	-	-	276.02	15.13	276.02
Other Long-Term Assets	0.13	0.13	-	-	-
Total Assets	1.34	5.41	279.13	22.33	279.13
Accounts Payable	0.56	1.48	1.51	2	1.51
Short-Term Debt	1.44	19.97	13.18	17.54	13.18
Other Current Liabilities	0.86	3.29	10.42	11.37	10.42
Total Current Liabilities	2.86	24.75	15.45	21.24	15.45
Other Long-Term Liabilities	0.12	-	10.53	0.94	10.53
Total Long-Term Liabilities	0.12	-	10.53	0.94	10.53
Total Liabilities	2.99	24.75	35.64	31.85	35.64
Common Stock	0	0	0.27	4.17	0.27
Additional Paid-in Capital	29.05	9.32	5.56	5.3	5.56
Retained Earnings	-30.7	-28.67	-38.34	-34.11	-38.34
Total Common Shareholders' Equity	-1.65	-19.34	-32.51	-24.64	-32.51
Minority Interest	-	-	276	15.13	276
Shareholders' Equity	-1.65	-19.34	243.49	-9.52	243.49
Total Liabilities & Equity	1.34	5.41	279.13	22.33	279.13
Total Debt	1.44	19.97	13.18	17.54	13.18
Net Cash (Debt)	-0.72	-19.92	-12.85	-12.21	-12.85
Net Cash Per Share	-0.04	-2.77	-4.22	-	-
Book Value	-1.65	-19.34	-32.51	-24.64	-32.51
Book Value Per Share	-0.09	-2.69	-10.69	-	-
Tangible Book Value	-1.65	-19.34	-32.51	-24.64	-32.51
Tangible Book Value Per Share	-0.09	-2.69	-10.69	-	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q